Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a selective cyclooxygenase-2 inhibitor.
Valdecoxib was manufactured and marketed under the brand name Bextra by G. D. Searle & Company as an anti-inflammatory arthritis drug. It was approved by the United States Food and Drug Administration on November 20, 2001, to treat arthritis and menstrual cramps. and was available by prescription in tablet form until 2005 when the FDA requested that Pfizer withdraw Bextra from the American market. The FDA cited "potential increased risk for serious cardiovascular (CV) adverse events," an "increased risk of serious skin reactions" and the "fact that Bextra has not been shown to offer any unique advantages over the other available NSAIDs."
Specifications:
Molecular formula: C16H14N2O3S
Molecular weight: 314.359
Density: 1.303 g/cm3
Melting point: 162-164 ℃
Boiling point: 481.2 ° C at 760 mmHg
Flash: 244.8 ° C
Vapor pressure: 2.03 e-09 mmHg at 25 ° C
Storage ：Store in cool and dry palce. Keep away from strong light ,high temperature.
Usage: Used as pharmaceutical intermediates
transportation：by express delivery or sea shipping.
Sample: At any time to provide (lowest price & highest quality)
没有评论:
发表评论